<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04912947</url>
  </required_header>
  <id_info>
    <org_study_id>EVAANIS</org_study_id>
    <nct_id>NCT04912947</nct_id>
  </id_info>
  <brief_title>EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)</brief_title>
  <acronym>EVAANIS</acronym>
  <official_title>EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complife Italia Srl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Macrofarm Srl</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Icim International Srl</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Complife Italia Srl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary&#xD;
      supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy&#xD;
      adult subjects with high baseline levels of oxidative stress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 30, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Erythrocytes GSH/GSSG ratio</measure>
    <time_frame>Month 3</time_frame>
    <description>Change from Baseline reduced/oxidized glutathione ratio in erythrocytes at 3 Months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Erythrocytes GSH/GSSG ratio</measure>
    <time_frame>Month 1</time_frame>
    <description>Change from Baseline reduced/oxidized glutathione ratio in erythrocytes at 1st Month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Immune system activity</measure>
    <time_frame>Month 3</time_frame>
    <description>Change from Baseline of Serum levels of immune system activity: TNFα, IL-6, IL-2 at 3 Months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Immune system activity</measure>
    <time_frame>Month 1</time_frame>
    <description>Change from Baseline of Serum levels of immune system activity: TNFα, IL-6, IL-2 at 1st Month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Immune system activity</measure>
    <time_frame>Month 3</time_frame>
    <description>Change from Baseline of Serum levels of IFN-γ at 1st Month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Immune system activity</measure>
    <time_frame>Month 1</time_frame>
    <description>Change from Baseline of Serum levels of IFN-γ at 1st Month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Dietary supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One cp/day of the IMMUSYSTEM food supplement for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One cp/day of Placebo for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Immusystem</intervention_name>
    <description>Dietary supplement containing: Piceid, Glycine, Glutamine, Acetylcysteine, Zinc and Vitamin B6</description>
    <arm_group_label>Dietary supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin placebo capsule</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Caucasian ethnicity;&#xD;
&#xD;
          -  Age between 30 and 65 years;&#xD;
&#xD;
          -  Smokers who have smoked at least 100 cigarettes in their lifetime and smoke at least&#xD;
             10 cigarettes a day;&#xD;
&#xD;
          -  Sportsmen who have been playing sports for at least 6 months between 4 and 8 hours per&#xD;
             week;&#xD;
&#xD;
          -  Signature of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic pathologies;&#xD;
&#xD;
          -  Active drug therapy;&#xD;
&#xD;
          -  Estrogen-progestogen therapy;&#xD;
&#xD;
          -  Pregnancy;&#xD;
&#xD;
          -  Allergies to the components of the raw material under study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Puoci, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DFSSN - UNICAL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Calabria</name>
      <address>
        <city>Rende</city>
        <state>CS</state>
        <zip>87036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calabria</investigator_affiliation>
    <investigator_full_name>FRANCESCO PUOCI</investigator_full_name>
    <investigator_title>Associate Professor - DFSSN</investigator_title>
  </responsible_party>
  <keyword>Oxidative Stress</keyword>
  <keyword>Glutathione</keyword>
  <keyword>Immune system activity</keyword>
  <keyword>Food supplement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

